Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma
Dimpy Koul(The University of Texas MD Anderson Cancer Center), W.K. Alfred Yung(The University of Texas MD Anderson Cancer Center)
Cited by 21
Related Papers
The multilayered transcriptional architecture of glioblastoma ecosystems
|Nature Genetics|2025|90